title: L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells.
abstract: Opening of dihydropyridine-sensitive voltage-dependent L-type Ca2+-channels (LTCCs) represents the final common pathway for insulin secretion in pancreatic beta-cells and related cell lines. In insulin-secreting cells their exact subunit composition is unknown. We therefore investigated the subunit structure of (+)-[3H]isradipine-labeled LTCCs in insulin-secreting RINm5F cells. Using subunit-specific antibodies we demonstrate that alpha1C subunits (199 kDa, short form) contribute only a minor portion of the total alpha1 immunoreactivity in membranes and partially purified Ca2+-channel preparations. However, alpha1C forms a major constituent of (+)-[3H]isradipine-labeled LTCCs as 54% of solubilized (+)-[3H]isradipine-binding activity was specifically immunoprecipitated by alpha1C antibodies. Phosphorylation of immunopurified alpha1C with cAMP-dependent protein kinase revealed the existence of an additional 240-kDa species (long form), that remained undetected in Western blots. Fifty seven percent of labeled LTCCs were immunoprecipitated by an anti-beta-antibody directed against all known beta-subunits. Isoform-specific antibodies revealed that these mainly corresponded to beta1b- and beta3-subunits. We found beta2- and beta4-subunits to be major constituents of cardiac and brain L-type channels, respectively, but not part of L-type channels in RINm5F cells. We conclude that alpha1C is a major constituent of dihydropyridine-labeled LTCCs in RINm5F cells, its long form serving as a substrate for cAMP-dependent protein kinase. beta1b- and beta3-Subunits were also found to associate with L-type channels in these cells. These isoforms may therefore represent biochemical targets for the modulation of LTCC activity in RINm5F cells.
authors.affiliation: Pharmazeutisches Institut, Lehrstuhl Pharmakologie, Universität Tübingen, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Safayhi
authors.forename: H
authors.initials: H
authors.lastname: Haase
authors.forename: U
authors.initials: U
authors.lastname: Kramer
authors.forename: A
authors.initials: A
authors.lastname: Bihlmayer
authors.forename: M
authors.initials: M
authors.lastname: Roenfeldt
authors.forename: H P
authors.initials: HP
authors.lastname: Ammon
authors.forename: M
authors.initials: M
authors.lastname: Froschmayr
authors.forename: T N
authors.initials: TN
authors.lastname: Cassidy
authors.forename: I
authors.initials: I
authors.lastname: Morano
authors.forename: M K
authors.initials: MK
authors.lastname: Ahlijanian
authors.forename: J
authors.initials: J
authors.lastname: Striessnig
mesh_terms: D015220:Calcium Channels / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007340:Insulinoma; D007515:Islets of Langerhans / Q000378:metabolism*; D010766:Phosphorylation; D014407:Tumor Cells, Cultured
chemical_list: D015220:Calcium Channels; D007328:Insulin